Switch to:
Biomarin Pharmaceutical Inc (NAS:BMRN)
Additional Paid-In Capital
$3,458.1 Mil (As of Jun. 2016)

Biomarin Pharmaceutical Inc's quarterly additional paid-in capital declined from Dec. 2015 ($3,414.8 Mil) to Mar. 2016 ($3,410.3 Mil) but then increased from Mar. 2016 ($3,410.3 Mil) to Jun. 2016 ($3,458.1 Mil).

Biomarin Pharmaceutical Inc's annual additional paid-in capital increased from Dec. 2013 ($2,059.1 Mil) to Dec. 2014 ($2,359.7 Mil) and increased from Dec. 2014 ($2,359.7 Mil) to Dec. 2015 ($3,414.8 Mil).


Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)*Shares Outstanding

Related Terms

Shares Outstanding

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Biomarin Pharmaceutical Inc Annual Data

AdditionalPaidInCapital 709.4794.9852.9900.01,090.21,197.11,561.92,059.12,359.73,414.8

Biomarin Pharmaceutical Inc Quarterly Data

AdditionalPaidInCapital 2,213.32,249.42,278.82,359.73,308.13,337.53,371.43,414.83,410.33,458.1
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)